New Drugs: Faricimab-svoa (Vabysmo™) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti™) for Glaucoma and Ocular Hypertension.
{"title":"New Drugs: Faricimab-svoa (Vabysmo<sup>™</sup>) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti<sup>™</sup>) for Glaucoma and Ocular Hypertension.","authors":"Lana Gettman","doi":"10.4140/TCP.n.2023.497","DOIUrl":null,"url":null,"abstract":"<p><p>Two drugs are covered in this quarterly column. Faricimab-svoa (Vabysmo<sup>™</sup>) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti<sup>™</sup>) for Glaucoma and Ocular Hypertension.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"38 12","pages":"497-500"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2023.497","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Two drugs are covered in this quarterly column. Faricimab-svoa (Vabysmo™) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti™) for Glaucoma and Ocular Hypertension.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
